5-Amino-1MQRelated non-peptide compound
5-Amino-1MQ is a small-molecule inhibitor studied in metabolic research. It is often sold alongside peptides, but it is not a peptide and its preclinical results should not be presented as established human fat loss.
Before comparing this entry. This name is retained to reconcile the source index. Its classification needs separate checking; inclusion does not establish that it is a peptide.
What is 5-Amino-1MQ?
5-Amino-1MQ is a non-peptide chemical compound investigated as an inhibitor of nicotinamide N-methyltransferase (NNMT). It is not an ordinary vitamin supplement.
How it works
NNMT participates in nicotinamide metabolism and uses a methyl donor. Inhibiting it can affect interconnected cellular metabolic processes in experimental systems.
Effects studied
What does the evidence show?
Cell and animal metabolic research
Start with the right identity
5-Amino-1MQ is a chemical compound investigated for inhibition of nicotinamide N-methyltransferase, usually shortened to NNMT. NNMT participates in nicotinamide metabolism and uses a methyl donor. The enzyme belongs to networks involved in cellular metabolism. An inhibitor of it is not an ordinary vitamin supplement.
Why researchers study the target
Changes in NNMT activity have been linked to metabolic processes in experimental systems. Researchers ask whether inhibiting the enzyme changes energy handling, fat accumulation or other cellular outcomes. These studies can identify a potentially useful target before a treatment has been established.
What animal studies leave open
An effect in cultured cells or mice does not tell us the effective human exposure, the balance of benefits and harms, or which patients might respond. Results involving another NNMT inhibitor also should not be credited automatically to 5-Amino-1MQ. Chemical identity matters even within the same research class.
What human studies would need to measure
A human programme would need to examine pharmacology, tolerability and clinically meaningful outcomes with a defined product. Weight, metabolic markers and physical function would still be separate endpoints. Descriptions such as “boosts NAD” or “switches on fat burning” compress a complicated pathway into a promise the existing preclinical account cannot support.
Safety & status
Human pharmacology and tolerability require a defined preparation and clinical study. Findings for another NNMT inhibitor cannot establish the safety of 5-Amino-1MQ.
Country and product status
Country-specific product availability and authorisation require a separate current check.
Frequently asked questions
Is 5-Amino-1MQ a peptide?
No. It is a chemical NNMT inhibitor, despite appearing in some peptide collections.
Does NNMT inhibition prove weight loss in people?
No. A molecular target and experimental metabolic effects are not a demonstrated human weight-loss result.
Sources
This entry was rewritten from our research archive. References below are reading leads unless a completed check is explicitly noted; a full independent evidence and regulatory review is still pending.
- 5-Amino-1MQ · retained archive reference Archive research lead · Retained archive reference; not independently checked for this draft
- 5-Amino-1MQ · retained archive reference Archive research lead · Retained archive reference; not independently checked for this draft
Research provenance
This name was discovered in the Superpower peptide index, archived 26 October 2026. Its ratings and reviewer attribution have not been adopted as our own. The archive informed this original editorial draft; independent source review is still pending.